The growing global burden of type 2 diabetes and the increasing adoption of innovative glucose-lowering therapies are driving significant growth in the Antidiabetic SGLT-2 Inhibitor Market. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce blood glucose levels by preventing glucose reabsorption in the kidneys and have demonstrated additional cardiovascular and renal benefits....